Report Highlights
The global pulmonary drug delivery systems market should reach $76.9 billion by 2027 from $57.4 billion in 2022 at a compound annual growth rate (CAGR) of 6.0% for the forecast period of 2022 to 2027.
Report Includes
- 44 tables
- A brief overview and up-to-date analysis of the global markets for pulmonary drug delivery systems
- Analyses of the global market trends, with historic market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the actual market size and revenue forecast for pulmonary drug delivery systems in USD value terms, and their corresponding market share analysis by type of drug delivery systems, application/disease area and region
- Highlights of the major pulmonary diseases with detailed epidemiology for major disease areas such as asthma, COPD and cystic fibrosis; also, an industry-wide assessment of the key developments, novel products, recent approvals, R&D activities, pipeline products and blockbuster drugs
- In-depth information (facts and figures) concerning market drivers, opportunities and challenges, and other macroeconomic forces affecting the global pulmonary drug delivery systems market
- Holistic review of the international regulatory landscape for pulmonary drug delivery systems with emphasis on recently approved products as well as products under development or in different stages of clinical trials
- Updated information on key mergers and acquisition deals, agreements, collaborations and other impactful strategies adopted by key players in the global pulmonary drug delivery systems market
- Assessment of the recent patents published and granted on pulmonary drug delivery systems and related technologies
- Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
- Descriptive company profiles of the market leading players, including Abbott, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Lupin and Pfizer Inc.
Report Scope
This report will provide a detailed look at the pulmonary drug delivery systems market, highlighting major pulmonary diseases with detailed epidemiology for major disease areas such as asthma, COPD and cystic fibrosis. The report includes an industry-wide assessment of the novel products, launches, recent approvals, R&D pipeline and blockbuster drugs.
In the report, the regulatory scenario of pulmonary drug delivery systems is discussed for each device type. This will include products approved by regulatory authorities in recent years. Products under development or in different stages of clinical trials are also analyzed.
The report includes profiles of major companies in the market for pulmonary drug delivery systems, with overviews of their key product offerings and financials.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||
| Forecast period considered | 2022 to 2027 | ||||||||||||||||
| Base year market size | $54.1 billion | ||||||||||||||||
| Market size forecast | $76.9 billion | ||||||||||||||||
| Growth rate | CAGR of 6.0% for the forecast period of 2022-2027 | ||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||
| Segments covered | Type, Disease Area, and Region | ||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World (ROW) | ||||||||||||||||
| Countries covered | U.S., Canada, Mexico, U.K., Germany, France, Russia, Italy, Rest of Europe, China, India, Japan, South Korea, Rest of Asia-Pacific, South America, and Middle East and Africa (MEA) | ||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global pulmonary drug delivery systems market totaled $38.1 billion in 2017 and is estimated to reach $47.0 billion by 2022, growing at a compound annual growth rate (CAGR) of 4.3% for the period of 2017-2022.
Report Includes
- 74 tables
- A detailed overview and analysis of the global markets for pulmonary drug delivery systems
- Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- Assessments of pulmonary drug delivery systems by regions, delivery systems/types, and disease areas
- A look at the regulatory environment, which has been a driving force in the healthcare industry
- Reviews of key developments, novel product innovations, and recent strategic industry activities of major players across various product categories
- Detailed profiles of major vendors in the market, including 3M Pharmaceuticals Inc., AstraZeneca plc, Cipla Inc., GlaxoSmithKline plc and Lupin Ltd
Report Highlights
The global market for pulmonary drug delivery technologies reached $32.4 billion in 2013 and is expected to grow to $43.9 billion in 2018, with a compound annual growth rate (CAGR) of 6.2%.
Report Includes
- A detailed overview and thorough analysis of the present and future global markets for pulmonary drug delivery technologies
- Analyses of global market trends, with data from 2012 and 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Identification of emerging pulmonary drug delivery technologies, particularly with regard to inhaled drug delivery systems
- Information on technological developments, product innovations, and recent strategic industry activities of major players across different product categories
- Examination of devices currently being used for drug delivery to the lungs, new developments, spending trends, and revenue prospects for these technologies
- Comprehensive profiles of leading companies in the industry.
Report Highlights
The global pulmonary drug delivery technologies market which was $19.6 billion in 2010 is expected to be around $22.5 billion by 2011. This global market is further projected to reach nearly $44 billion by 2016 at a compound annual growth rate (CAGR) of 14.3%.
Related Reports
Global Markets and Technologies for Advanced Drug Delivery Systems
The global market for advanced drug delivery systems is expected to increase from $262.6 billion in 2023 to $359.1 billion by the end of 2028, with a compound annual growth rate (CAGR) of 6.5% during the forecast period of 2023-2028.
Medical Devices Industry: Competitive Landscape 2021
This report discusses exhaustive coverage of the medical device industry and its competitive landscape in terms of major player market ranking and top medical devices. Company profiles of the top fifty medical device companies, innovative products and technologies, trends and market dynamics, competitive intelligence and regional trends are well-researched and analyzed in this report. The study includes tracking alliances, joint ventures, mergers and acquisitions, new product development and R&D in the medical device industry and the factors that will affect the industry in the coming years.
Global Markets for Drug-Device Combinations
The global drug-device combination products market should reach $149 billion by 2026 from $103.5 billion in 2021 at a compound annual growth rate (CAGR) of 7.6% for the forecast period of 2021 to 2026.
Global Medical Ventilators Market
The global market for medical ventilators should grow from $1.1 billion in 2019 to reach $2.1 billion by 2024, at a compound annual growth rate (CAGR) of 12.5% for the period of 2019-2024.
Recent Reports
Medical Robotics and Computer-assisted Surgery: The Global Market
The global market for medical robotics and computer-assisted surgery is expected to grow from $11.5 billion in 2023 and projected to reach $19.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets
The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.
Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials
The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.
Global Cleanroom Technology Market
The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.
Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets
The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.
Top Trending Reports
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Digital Therapeutics: A New Age Medicine
The goal of this report is to understand the current digital therapeutics scenario and to assess the market’s growth potential. This study explores market dynamics that impact the growth of the market. The main objective of the study is to present a comprehensive analysis of the current market and the future direction of the market.
AI in Mental Health: Global Market Outlook
The report provides an overview of the global AI in mental health market and analyzes market trends. Using 2021 as the base year, the report provides estimated market data for the forecast period, 2022-2027. Revenue forecasts for this period are segmented based on organization size, component, provider, type, industry, and geography. It also highlights major trends and challenges that affect the market and the vendor landscape.
Smart Waste Management Systems: Global Markets
The global smart waste management systems market should reach $451.5 billion by 2022 and $675.3 billion by 2027, with a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2022-2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More